Home › Breast Cancer › Texas › Amarillo
Breast Cancer clinical trials in Amarillo, TX
4 studies for Breast Cancer are looking for participants at sites in and around Amarillo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- The Don and Sybil Harrington Cancer Center, Amarillo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- The Don and Sybil Harrington Cancer Center, Amarillo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- The Don and Sybil Harrington Cancer Center, Amarillo
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RecruitingPhase 3
- Texas Oncology-West Texas, Amarillo
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. Learn about the types, diagnosis, and treatments.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY144 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN78 studies
- Los Angeles, CA73 studies
- Edison, NJ70 studies
- Queens, NY67 studies
- Durham, NC63 studies
- St. Louis, MO63 studies
- Chicago, IL59 studies
- Dallas, TX54 studies
- Philadelphia, PA51 studies
Other studies in Amarillo
- Non-Small Cell Lung Cancer9 studies
- Heart Failure8 studies
- Obesity7 studies
- Lung Cancer5 studies
- Overweight4 studies
- Cardiovascular Disease4 studies
- Blood Clots4 studies
- Coronary Artery Disease3 studies
- Colorectal Cancer3 studies
- Atrial Fibrillation3 studies
- Digestive Diseases3 studies
- Atherosclerosis3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.